8037 Stock Overview
An investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
China Biotech Services Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.36 |
| 52 Week High | HK$0.80 |
| 52 Week Low | HK$0.25 |
| Beta | -0.78 |
| 1 Month Change | -25.51% |
| 3 Month Change | 19.67% |
| 1 Year Change | -47.86% |
| 3 Year Change | -68.26% |
| 5 Year Change | -71.26% |
| Change since IPO | -96.96% |
Recent News & Updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26Recent updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08Shareholder Returns
| 8037 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -6.4% | 0.7% | 3.4% |
| 1Y | -47.9% | -14.2% | 28.0% |
Return vs Industry: 8037 underperformed the Hong Kong Healthcare industry which returned -14.2% over the past year.
Return vs Market: 8037 underperformed the Hong Kong Market which returned 28% over the past year.
Price Volatility
| 8037 volatility | |
|---|---|
| 8037 Average Weekly Movement | 16.0% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 13.9% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 8037's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8037's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 142 | n/a | cbshhk.com |
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through seven segments: Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Securities, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; trading of securities; insurance brokerage services; provision of boron neutron capture therapy services; money lending business; provision of logistic services; and property investment activities.
China Biotech Services Holdings Limited Fundamentals Summary
| 8037 fundamental statistics | |
|---|---|
| Market cap | HK$341.51m |
| Earnings (TTM) | -HK$144.88m |
| Revenue (TTM) | HK$62.08m |
5.7x
P/S Ratio-2.5x
P/E RatioIs 8037 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8037 income statement (TTM) | |
|---|---|
| Revenue | HK$62.08m |
| Cost of Revenue | HK$92.19m |
| Gross Profit | -HK$30.11m |
| Other Expenses | HK$114.77m |
| Earnings | -HK$144.88m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | -48.50% |
| Net Profit Margin | -233.39% |
| Debt/Equity Ratio | 40.7% |
How did 8037 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 12:29 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Biotech Services Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|